Loading viewer...
earnings
Format: PDF earnings
Gilead Sciences presents third quarter 2022 financial and operational results, including commercial performance across virology, oncology and other programs. The presentation discusses progress on key product candidates, clinical trial updates, and the impact of COVID-19 and Veklury on business operations.
earnings
59 Pages
earnings
13 Pages
Magnite
McCormick Q2 2016 Earnings Financial Results
earningsearnings
33 Pages
McCormick & Company
Kirin Holdings 2016 Financial Results 2017 Business Plan
earningsearnings
69 Pages
Kirin Holdings Company Limited
AIA Engineering Q1 FY2018-19 Earnings Presentation
earningsearnings
11 Pages
AIA Engineering Limited